Evaluation of Intracoronary Hyperoxemic Oxygen Therapy in Anterior Acute Myocardial Infarction Patients (IC-HOT)
Completed · Not applicable
Conditions studied: Anterior Wall Acute Myocardial Infarction
In brief
The primary objective of the study is to collect confirmatory data supporting the safety and effectiveness of SSO2 Therapy in treatment of anterior acute myocardial infarction (AMI) patients who have undergone successful percutaneous coronary intervention (PCI) with stenting within six hours of experiencing AMI symptoms.
Key facts
- Study ID
- NCT02603835
- Run by
- TherOx
- People needed
- 100
- Starts
- 2016-02-01
- Expected to finish
- 2018-05-17
- Last updated by the study team
- 2023-09-15
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Heart Center, Inc. — Huntsville, Alabama, United States
- Scripps Hospital — La Jolla, California, United States
- Danbury Hospital — Danbury, Connecticut, United States
- Alexian Brothers Heart & Vascular Institute — Elk Grove Village, Illinois, United States
- Baystate Medical Center — Springfield, Massachusetts, United States
- Henry Ford Medical Center — Detroit, Michigan, United States
- St. John Hospital & Medical Center — Detroit, Michigan, United States
- Beaumont Hospital — Royal Oak, Michigan, United States
- Providence-Providence Park Hospital — Southfield, Michigan, United States
- WakeMed Heart Center — Raleigh, North Carolina, United States
- Lehigh Valley Hospital — Allentown, Pennsylvania, United States
- Holy Spirit Cardiology — Camp Hill, Pennsylvania, United States
- Geisinger Medical Center — Danville, Pennsylvania, United States
- The Miriam Hospital/Rhode Island Hospital — Providence, Rhode Island, United States
- Wellmont CVA Heart Institute — Kingsport, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.